(KADN/AP) - The Food and Drug Administration has granted emergency use approval for the use of the Pfizer-BioNTech COVID-19 vaccine for children 12 to 15 years of age.
This comes nearly five months after the FDA approved the use of the vaccine for those 16-years and older.
According to tweets from the FDA, they "determined that Pfizer-BioNTech COVID-19 Vaccine has met the statutory criteria to amend the EUA, and that the known and potential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks, supporting the vaccine’s use."
The FDA said Monday the shot is safe and offers strong protection for younger teens based on testing of more than 2,000 U.S. volunteers.
Shots could once a federal vaccine panel issues recommendations for using the vaccine in 12- to 15-year-olds.
Most vaccines rolling out worldwide have been authorized for adults.